Frequent Loss of Expression and Loss of Heterozygosity of the Putative Tumor Suppressor Gene DCC in Prostatic Carcinomas

David Grignon, Wael Sakr, Yong Q. Chen

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

The putative tumor suppressor gene DCC has been shown to be frequently lost or expressed at low levels in colorectal, gastric, pancreatic, and esophageal carcinomas. In the present study, the DCC gene and its mRNA expression in human and rat prostatic carcinoma cells as well as in prostatic carcinoma tissues were examined by reverse transcriptase-polymerase chain reaction and polymerase chain reaction-loss of heterozygosity. The DCC gene was present and expressed in normal prostatic cells. However, its expression was decreased or undetectable in all prostatic carcinoma cells from either humans (4 cell lines) or rats (5 cell lines). In patients, 12 of 14 cases (86%) showed reduced DCC expression and 5 of 11 informative cases (45%) showed loss of heterozygosity at the DCC locus. These results demonstrate that loss of DCC expression and loss of heterozygosity at the DCC locus are a frequent feature of prostatic carcinoma cells.

Original languageEnglish (US)
Pages (from-to)2723-2727
Number of pages5
JournalCancer Research
Volume53
Issue number12
StatePublished - Jun 1993

Fingerprint

Loss of Heterozygosity
Tumor Suppressor Genes
DCC Genes
Carcinoma
Cell Line
Reverse Transcriptase Polymerase Chain Reaction
Stomach
Polymerase Chain Reaction
Messenger RNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Frequent Loss of Expression and Loss of Heterozygosity of the Putative Tumor Suppressor Gene DCC in Prostatic Carcinomas. / Grignon, David; Sakr, Wael; Chen, Yong Q.

In: Cancer Research, Vol. 53, No. 12, 06.1993, p. 2723-2727.

Research output: Contribution to journalArticle

Grignon, David ; Sakr, Wael ; Chen, Yong Q. / Frequent Loss of Expression and Loss of Heterozygosity of the Putative Tumor Suppressor Gene DCC in Prostatic Carcinomas. In: Cancer Research. 1993 ; Vol. 53, No. 12. pp. 2723-2727.
@article{fc4477f74e2f4150846065ea9fb38347,
title = "Frequent Loss of Expression and Loss of Heterozygosity of the Putative Tumor Suppressor Gene DCC in Prostatic Carcinomas",
abstract = "The putative tumor suppressor gene DCC has been shown to be frequently lost or expressed at low levels in colorectal, gastric, pancreatic, and esophageal carcinomas. In the present study, the DCC gene and its mRNA expression in human and rat prostatic carcinoma cells as well as in prostatic carcinoma tissues were examined by reverse transcriptase-polymerase chain reaction and polymerase chain reaction-loss of heterozygosity. The DCC gene was present and expressed in normal prostatic cells. However, its expression was decreased or undetectable in all prostatic carcinoma cells from either humans (4 cell lines) or rats (5 cell lines). In patients, 12 of 14 cases (86{\%}) showed reduced DCC expression and 5 of 11 informative cases (45{\%}) showed loss of heterozygosity at the DCC locus. These results demonstrate that loss of DCC expression and loss of heterozygosity at the DCC locus are a frequent feature of prostatic carcinoma cells.",
author = "David Grignon and Wael Sakr and Chen, {Yong Q.}",
year = "1993",
month = "6",
language = "English (US)",
volume = "53",
pages = "2723--2727",
journal = "Cancer Research",
issn = "0008-5472",
number = "12",

}

TY - JOUR

T1 - Frequent Loss of Expression and Loss of Heterozygosity of the Putative Tumor Suppressor Gene DCC in Prostatic Carcinomas

AU - Grignon, David

AU - Sakr, Wael

AU - Chen, Yong Q.

PY - 1993/6

Y1 - 1993/6

N2 - The putative tumor suppressor gene DCC has been shown to be frequently lost or expressed at low levels in colorectal, gastric, pancreatic, and esophageal carcinomas. In the present study, the DCC gene and its mRNA expression in human and rat prostatic carcinoma cells as well as in prostatic carcinoma tissues were examined by reverse transcriptase-polymerase chain reaction and polymerase chain reaction-loss of heterozygosity. The DCC gene was present and expressed in normal prostatic cells. However, its expression was decreased or undetectable in all prostatic carcinoma cells from either humans (4 cell lines) or rats (5 cell lines). In patients, 12 of 14 cases (86%) showed reduced DCC expression and 5 of 11 informative cases (45%) showed loss of heterozygosity at the DCC locus. These results demonstrate that loss of DCC expression and loss of heterozygosity at the DCC locus are a frequent feature of prostatic carcinoma cells.

AB - The putative tumor suppressor gene DCC has been shown to be frequently lost or expressed at low levels in colorectal, gastric, pancreatic, and esophageal carcinomas. In the present study, the DCC gene and its mRNA expression in human and rat prostatic carcinoma cells as well as in prostatic carcinoma tissues were examined by reverse transcriptase-polymerase chain reaction and polymerase chain reaction-loss of heterozygosity. The DCC gene was present and expressed in normal prostatic cells. However, its expression was decreased or undetectable in all prostatic carcinoma cells from either humans (4 cell lines) or rats (5 cell lines). In patients, 12 of 14 cases (86%) showed reduced DCC expression and 5 of 11 informative cases (45%) showed loss of heterozygosity at the DCC locus. These results demonstrate that loss of DCC expression and loss of heterozygosity at the DCC locus are a frequent feature of prostatic carcinoma cells.

UR - http://www.scopus.com/inward/record.url?scp=0027156230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027156230&partnerID=8YFLogxK

M3 - Article

C2 - 8504411

AN - SCOPUS:0027156230

VL - 53

SP - 2723

EP - 2727

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 12

ER -